Depression-induced dysregulation of the ANS, characterized by increased sympathetic activity and reduced parasympathetic tone, worsens glycemic control by impairing insulin secretion and promoting hepatic glucose output [138]. The gene discussed is INS; the disease is depressive symptom measurement.